coinables

IMGN Oversold and Below MAs, 8% Oppty

NASDAQ:IMGN   ImmunoGen, Inc
IMGN is potentially bouncing from recently being oversold territory and extended below short and longer moving averages. Target is at ~9.78 (8% above current prices) based on previous structure.